Central nervous system remyelination clinical application of basic neuroscience principles

David J. Miller, Kuni Asakura, Moses Rodriguez

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Studies in both humans and experimental animals have demonstrated that myelin repair in the CNS is a normal physiological response to myelin damage, similar to tissue injury elsewhere in the body. The unanswered question is why myelin repair is incomplete in multiple sclerosis patients. In this paper we review the morphological characteristics of remyelination, discuss the available animal models of CNS demyelination and their usefulness to identify the molecular, cellular, and morphological events involved in CNS myelin repair, examine the use of immunosuppression, immunoglobulins, protein growth factors, and glial cell transplantation as the primary experimental therapies designed to promote CNS remyelination, and address the potential electrophysiological and clinical benefits of myelin repair in the CNS.

Original languageEnglish (US)
Pages (from-to)331-344
Number of pages14
JournalBrain Pathology
Volume6
Issue number3
StatePublished - Jul 1996

Fingerprint

Neurosciences
Myelin Sheath
Central Nervous System
Investigational Therapies
Cell Transplantation
Demyelinating Diseases
Neuroglia
Immunosuppression
Multiple Sclerosis
Immunoglobulins
Intercellular Signaling Peptides and Proteins
Animal Models
Wounds and Injuries
Proteins

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine

Cite this

Miller, D. J., Asakura, K., & Rodriguez, M. (1996). Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathology, 6(3), 331-344.

Central nervous system remyelination clinical application of basic neuroscience principles. / Miller, David J.; Asakura, Kuni; Rodriguez, Moses.

In: Brain Pathology, Vol. 6, No. 3, 07.1996, p. 331-344.

Research output: Contribution to journalArticle

Miller, DJ, Asakura, K & Rodriguez, M 1996, 'Central nervous system remyelination clinical application of basic neuroscience principles', Brain Pathology, vol. 6, no. 3, pp. 331-344.
Miller, David J. ; Asakura, Kuni ; Rodriguez, Moses. / Central nervous system remyelination clinical application of basic neuroscience principles. In: Brain Pathology. 1996 ; Vol. 6, No. 3. pp. 331-344.
@article{6d50ec39e9af44e0b7a61c4846d00985,
title = "Central nervous system remyelination clinical application of basic neuroscience principles",
abstract = "Studies in both humans and experimental animals have demonstrated that myelin repair in the CNS is a normal physiological response to myelin damage, similar to tissue injury elsewhere in the body. The unanswered question is why myelin repair is incomplete in multiple sclerosis patients. In this paper we review the morphological characteristics of remyelination, discuss the available animal models of CNS demyelination and their usefulness to identify the molecular, cellular, and morphological events involved in CNS myelin repair, examine the use of immunosuppression, immunoglobulins, protein growth factors, and glial cell transplantation as the primary experimental therapies designed to promote CNS remyelination, and address the potential electrophysiological and clinical benefits of myelin repair in the CNS.",
author = "Miller, {David J.} and Kuni Asakura and Moses Rodriguez",
year = "1996",
month = "7",
language = "English (US)",
volume = "6",
pages = "331--344",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Central nervous system remyelination clinical application of basic neuroscience principles

AU - Miller, David J.

AU - Asakura, Kuni

AU - Rodriguez, Moses

PY - 1996/7

Y1 - 1996/7

N2 - Studies in both humans and experimental animals have demonstrated that myelin repair in the CNS is a normal physiological response to myelin damage, similar to tissue injury elsewhere in the body. The unanswered question is why myelin repair is incomplete in multiple sclerosis patients. In this paper we review the morphological characteristics of remyelination, discuss the available animal models of CNS demyelination and their usefulness to identify the molecular, cellular, and morphological events involved in CNS myelin repair, examine the use of immunosuppression, immunoglobulins, protein growth factors, and glial cell transplantation as the primary experimental therapies designed to promote CNS remyelination, and address the potential electrophysiological and clinical benefits of myelin repair in the CNS.

AB - Studies in both humans and experimental animals have demonstrated that myelin repair in the CNS is a normal physiological response to myelin damage, similar to tissue injury elsewhere in the body. The unanswered question is why myelin repair is incomplete in multiple sclerosis patients. In this paper we review the morphological characteristics of remyelination, discuss the available animal models of CNS demyelination and their usefulness to identify the molecular, cellular, and morphological events involved in CNS myelin repair, examine the use of immunosuppression, immunoglobulins, protein growth factors, and glial cell transplantation as the primary experimental therapies designed to promote CNS remyelination, and address the potential electrophysiological and clinical benefits of myelin repair in the CNS.

UR - http://www.scopus.com/inward/record.url?scp=0030037331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030037331&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 331

EP - 344

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 3

ER -